key: cord-1030097-58172gjo
authors: Davies, Emma; Whitfield, Tom; Machin, Nicholas; Ahmad, Shazaad
title: The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing
date: 2020-05-20
journal: J Clin Virol
DOI: 10.1016/j.jcv.2020.104449
sha: be0f5675a6ee2d73bd1bf9aeea2fa58a87acc2e1
doc_id: 1030097
cord_uid: 58172gjo

nan

1

Emma Davies 1 , Tom Whitfield 1* tomwhitfield@doctors.org.uk , Nicholas Machin 1 , Shazaad Ahmad 1 . We note that 'Nose and Throat' swabs and 'Throat' swabs failed the cellular control more commonly than 'Nasal swabs' alone (1.7%vs 0.7% p=<0.01 chi squared) and samples failing the cellular control had a significantly lower proportion of positive tests for COVID-19 than those which passed (11.6 % vs 5.4% p= 0.02).

These findings show inadequate sampling as measured by human cellular control is a phenomena confined to swabs and that throat swabs were the most frequent poorly taken sample. This information is highly pertinent to health care practitioners collecting clinical samples and reinforces We surmise human cellular control testing has an adjunctive role in ensuring quality sampling and test accuracy. Though the control does not fully ensure the sample is correctly taken, it is instructive and reassuring to those collecting samples. Most importantly, we evidence a reduction in the possibility of false-negative results and the inherent potential for ongoing harm that could result. 3 We are also pleased to acknowledge that only a minority of our samples were cellular control failures meaning poor sampling is uncommon in our population. If generalisable, our findings indicate poor sampling is not a major contributor towards the high numbers of false negative results reported. 4 We would like to commend and encourage the continued good practice of frontline staff. 

Endogenous Control (VIC™/MGB probe, primer limited)[online] United Kingdom

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Positive RT-PCR Test Results in Patients Recovered From COVID-19

Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. medRxiv